Anticancer agent 135
Anticancer agent 135 is a potent androgen receptor antagonist that inhibits AR nuclear translocation and disrupts AR/AR-V7 dimerization, suppressing oncogenic transcription. It demonstrates robust antitumor activity in both cellular assays and prostate cancer xenograft models, supporting its use in AR-driven cancer research.
Product Specifications
Field of Research
Metabolism Research
Molecular Formula
C23H21F3N4OS
Molecular Weight
458.5
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog